HCAT Stock Analysis: Buy, Sell, or Hold?
HCAT - Health Catalyst, Inc Common Stock
$2.29
0.05 (2.23%)
▲
5d:
+10.1%
30d:
+33.92%
90d:
+126.73%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Get Alerted When HCAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: HCAT is 12.3% above its trading range ($2.04). Market expects 37.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: HCAT is 12.3% above its trading range ($2.04). Market expects 37.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: HCAT is currently trading at $2.29, which is considered extended relative to its 30-day fair value range of $1.54 to $2.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.8) compared to its historical average (9.6). At these levels, the market is pricing in 37.4% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, HCAT is in a strong downtrend. The price is approaching resistance at $2.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HCAT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $1.90. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HCAT is in a strong downtrend. The price is approaching resistance at $2.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HCAT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $1.90. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.54 -
$2.04
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
38.1%
Protect Your Profits
HCAT is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 17.0% above Wall St target ($1.90)
- BEARISH: Market expects 37.4% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$1.54 -
$2.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.24
Resistance Level
$2.23
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.81
Wall Street Target
$1.90
(-17.0%)
Revenue Growth (YoY)
-10.9%
Profit Margin
-87.7%
Valuation Premium vs History
+37.4% premium
PE vs Historical
24.8 vs 9.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+37.4%
(market-implied from PE analysis)
1-Year Target
$3.15
(+37%)
2-Year Target
$4.32
(+89%)
3-Year Target
$5.94
(+159%)
3-Yr Target (if PE normalizes)
(PE: 25→10)
PE COMPRESSION
$2.30
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.8, Growth: 119.8%)
$7.73
(+238%)
Base:
(SPY PE: 21.8, Growth: 119.8%)
$6.78
(+196%)
Bear:
(PE: 9.6, Growth: 119.8%)
$2.99
(+31%)
Share & Embed Analysis
Last updated: July 13, 2026 3:06 AM ET
Data refreshes hourly during market hours. Next update: 4:06 AM
Data refreshes hourly during market hours. Next update: 4:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 63 BUY |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 63 BUY |
Advanced HCAT Option Strategies
Professional options setups generated by AI based on today's HCAT price and gamma walls.
